The PurpleLab^® Resource Center

This blog is part two in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Pharmaceutical manufacturers do more than just produce medications that line pharmacy and hospital shelves: they also need to closely observe and respond to market conditions, changing clinical guidelines, and safety regulations, to ensure that…

This blog is part one in a series exploring the use of real-world evidence to produce meaningful insights in clinical pharma.  Clinical trials are crucial for developing new medications and treatments, but they require meticulous pre-planning and feasibility assessments, which can be extremely time-consuming. Real-world evidence (RWE) offers a promising solution to expedite this process….

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…